Status:
COMPLETED
Evaluation of Liver Disease in Individuals Attending Alcohol Abuse Treatment - a Randomized Controlled Pilot Trial
Lead Sponsor:
Zealand University Hospital
Conditions:
Liver Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot study aims to evaluate the feasibility of a non-blinded randomized controlled trial with a parallel group design of an invitation to an evaluation of liver disease (intervention) compared t...
Detailed Description
Alcohol-related liver disease (ALD) is responsible for about 80% of all liver disease in Denmark. The prognosis for ALD is good, if detected early and abstinence is obtained. Unfortunately ALD is ofte...
Eligibility Criteria
Inclusion
- must be enrolled at alcohol treatment center Novavi Koege, Denmark
- Maximum 6 months of treatment at Novavi Koege
Exclusion
- known severe liver disease
- life expectancy less than 6 months
- unable to give informed written consent
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05244720
Start Date
November 1 2021
End Date
September 30 2022
Last Update
May 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine, Zealand University Hospital
Køge, Denmark, 4600